Published in Biotechniques on November 01, 1994
Rapid identification of methicillin-resistant Staphylococcus aureus and simultaneous species confirmation using real-time fluorescence PCR. J Clin Microbiol (2000) 3.82
Occurrence of nontuberculous mycobacteria in environmental samples. Appl Environ Microbiol (1999) 3.06
16S rRNA sequence diversity in Mycobacterium celatum strains caused by presence of two different copies of 16S rRNA gene. J Clin Microbiol (1998) 2.33
Identification and detection of Stenotrophomonas maltophilia by rRNA-directed PCR. J Clin Microbiol (2000) 1.90
Simultaneous detection of Staphylococcus aureus and coagulase-negative staphylococci in positive blood cultures by real-time PCR with two fluorescence resonance energy transfer probe sets. J Clin Microbiol (2004) 1.63
Real-time fluorescence PCR assays for detection and characterization of Shiga toxin, intimin, and enterohemolysin genes from Shiga toxin-producing Escherichia coli. J Clin Microbiol (2002) 1.61
Comparison of culture and PCR for detection of Burkholderia cepacia in sputum samples of patients with cystic fibrosis. J Clin Microbiol (1998) 1.50
Development of a single-tube, cell lysis-based, genus-specific PCR method for rapid identification of mycobacteria: optimization of cell lysis, PCR primers and conditions, and restriction pattern analysis. J Clin Microbiol (2004) 1.43
Gordona terrae central nervous system infection in an immunocompetent patient. J Clin Microbiol (1997) 1.41
Species-level identification of staphylococcal isolates by real-time PCR and melt curve analysis. J Clin Microbiol (2005) 1.36
Optimal detection and identification of Mycobacterium haemophilum in specimens from pediatric patients with cervical lymphadenopathy. J Clin Microbiol (1999) 1.08
Enhanced production of recombinant Mycobacterium tuberculosis antigens in Escherichia coli by replacement of low-usage codons. Infect Immun (2000) 1.08
Evaluation of a novel PCR-based diagnostic assay for detection of Mycobacterium tuberculosis in sputum samples. J Clin Microbiol (1996) 1.01
Investigation of biofilm forming ability in Staphylococci causing bovine mastitis using phenotypic and genotypic assays. ScientificWorldJournal (2013) 0.84
Combination of 16S rRNA variable regions provides a detailed analysis of bacterial community dynamics in the lungs of cystic fibrosis patients. Hum Genomics (2010) 0.79
Comparison of three rapid and easy bacterial DNA extraction methods for use with quantitative real-time PCR. Eur J Clin Microbiol Infect Dis (2011) 0.78
Recent developments in detection and enumeration of waterborne bacteria: a retrospective minireview. Microbiologyopen (2016) 0.75
Nasal carriage screening of community-associated methicillin resistant Staphylococcus aureus in healthy children of a developing country. Adv Biomed Res (2016) 0.75
Identification and characterization of conserved and variable regions in the envelope gene of HTLV-III/LAV, the retrovirus of AIDS. Cell (1986) 10.70
Computer-assisted analysis of envelope protein sequences of seven human immunodeficiency virus isolates: prediction of antigenic epitopes in conserved and variable regions. J Virol (1987) 6.20
The antigenic index: a novel algorithm for predicting antigenic determinants. Comput Appl Biosci (1988) 5.00
Polymorphic proteins encoded within BZLF1 of defective and standard Epstein-Barr viruses disrupt latency. J Virol (1987) 4.12
Occurrence of Epstein-Barr virus genomes in human lymphoblastoid cell lines. Nat New Biol (1972) 3.84
Characterization of a virtually full-length human immunodeficiency virus type 1 genome of a prevalent intersubtype (C/B') recombinant strain in China. J Virol (2000) 3.70
Activating K-Ras mutations outwith 'hotspot' codons in sporadic colorectal tumours - implications for personalised cancer medicine. Br J Cancer (2010) 3.25
N-acetyltransferase phenotype and risk in urinary bladder cancer: approaches in molecular epidemiology. Preliminary results in Sweden and Denmark. Environmental Health Perspectives;1979:71-79. Int J Epidemiol (2007) 3.13
EB viral genomes in epithelial nasopharyngeal carcinoma cells. Nat New Biol (1973) 2.71
Dose reduction in CT by anatomically adapted tube current modulation. I. Simulation studies. Med Phys (1999) 2.64
Clinical evaluation of the automated COBAS AMPLICOR MTB assay for testing respiratory and nonrespiratory specimens. J Clin Microbiol (1998) 2.61
Dose reduction in CT by anatomically adapted tube current modulation. II. Phantom measurements. Med Phys (1999) 2.29
Perinatal morbidity and mortality in early-onset fetal growth restriction: cohort outcomes of the trial of randomized umbilical and fetal flow in Europe (TRUFFLE). Ultrasound Obstet Gynecol (2013) 2.25
Identification of a region in the Pr55gag-polyprotein essential for HIV-1 particle formation. Virology (1993) 2.20
Kirromycin, an inhibitor of protein biosynthesis that acts on elongation factor Tu. Proc Natl Acad Sci U S A (1974) 1.97
Generation of neutralizing human monoclonal antibodies against parvovirus B19 proteins. J Virol (1999) 1.97
Nasopharyngeal carcinoma. X. Presence of epstein-barr genomes in separated epithelial cells of tumours in patients from Singapore, Tunisia and Kenya. Int J Cancer (1975) 1.95
Dose reduction in computed tomography by attenuation-based on-line modulation of tube current: evaluation of six anatomical regions. Eur Radiol (2000) 1.93
Bromocriptine lessens the incidence of mortality in L-dopa-treated parkinsonian patients: prado-study discontinued. Eur J Clin Pharmacol (1992) 1.86
Cloning and characterization of a virtually full-length HIV type 1 genome from a subtype B'-Thai strain representing the most prevalent B-clade isolate in China. AIDS Res Hum Retroviruses (1998) 1.83
E1B 55-kilodalton-associated protein: a cellular protein with RNA-binding activity implicated in nucleocytoplasmic transport of adenovirus and cellular mRNAs. J Virol (1998) 1.83
Multiple effects of codon usage optimization on expression and immunogenicity of DNA candidate vaccines encoding the human immunodeficiency virus type 1 Gag protein. J Virol (2001) 1.81
Usefulness of specific immunotherapy in patients with atopic dermatitis and allergic sensitization to house dust mites: a multi-centre, randomized, dose-response study. Allergy (2006) 1.80
Proline residues in the HIV-1 NH2-terminal capsid domain: structure determinants for proper core assembly and subsequent steps of early replication. Virology (2000) 1.77
Persistence of Epstein-Barr virus in the parotid gland. J Virol (1984) 1.75
Quantitative salivary gland scintigraphy in the diagnosis of parenchymal damage after treatment with radioiodine. Nucl Med Commun (1996) 1.67
Mechanism of the inhibition of protein synthesis by kirromycin. Role of elongation factor Tu and ribosomes. Eur J Biochem (1977) 1.63
High prevalence of hemostatic abnormalities in women with a history of severe preeclampsia. Am J Obstet Gynecol (1999) 1.60
Fetal and maternal diurnal rhythms during the third trimester of normal pregnancy: outcomes of computerized analysis of continuous twenty-four-hour fetal heart rate recordings. Am J Obstet Gynecol (1998) 1.60
Expression of Epstein-Barr virus genes in different cell types after microinjection of viral DNA. Proc Natl Acad Sci U S A (1980) 1.59
Identification of proteins encoded by Epstein-Barr virus trans-activator genes. J Virol (1989) 1.58
Specific cytotoxic T lymphocytes recognize the immediate-early transactivator Zta of Epstein-Barr virus. J Virol (1995) 1.57
Specific and sensitive two-step polymerase chain reaction assay for the detection of Salmonella species. Eur J Clin Microbiol Infect Dis (1996) 1.56
Specific immunotherapy in honeybee venom allergy: a comparative study using aqueous and aluminium hydroxide adsorbed preparations. Allergy (2004) 1.56
Purification and properties of Herpesvirus saimiri DNA. Virology (1974) 1.55
The adenovirus E4orf6 protein can promote E1A/E1B-induced focus formation by interfering with p53 tumor suppressor function. Proc Natl Acad Sci U S A (1997) 1.55
Safety of a two-day ultrarush insect venom immunotherapy protocol in comparison with protocols of longer duration and involving a larger number of injections. J Allergy Clin Immunol (2000) 1.55
Dose reduction in CT by on-line tube current control: principles and validation on phantoms and cadavers. Eur Radiol (1999) 1.53
Rev-independent expression of synthetic gag-pol genes of human immunodeficiency virus type 1 and simian immunodeficiency virus: implications for the safety of lentiviral vectors. Hum Gene Ther (2000) 1.52
Polymer-supported bilayer on a solid substrate. Biophys J (1992) 1.50
Proteome profiling of bladder squamous cell carcinomas: identification of markers that define their degree of differentiation. Cancer Res (1997) 1.49
Rapid detection of enterohemorrhagic Escherichia coli by real-time PCR with fluorescent hybridization probes. J Clin Microbiol (2001) 1.48
[Assessment of late pregnancy terminations, 2004-2007]. Ned Tijdschr Geneeskd (2008) 1.45
Structural analysis of the adenovirus type 5 E1B 55-kilodalton-E4orf6 protein complex. J Virol (1997) 1.44
N-acetyltransferase phenotype and risk in urinary bladder cancer: approaches in molecular epidemiology. Preliminary results in Sweden and Denmark. Environ Health Perspect (1979) 1.43
Radiotherapy with iodine-131 in recurrent malignant struma ovarii. Eur J Nucl Med (1996) 1.43
[Pyelonephritis during pregnancy: a threat to mother and child]. Ned Tijdschr Geneeskd (2007) 1.42
Bladder squamous cell carcinomas express psoriasin and externalize it to the urine. J Urol (1996) 1.42
Susceptibility of Legionella spp. to quinolone derivatives and related organic acids. Eur J Clin Microbiol (1984) 1.42
Effect of kirromycin on elongation factor Tu. Location of the catalytic center for ribosome-elongation-factor-Tu GTPase activity on the elongation factor. Eur J Biochem (1977) 1.41
Legionella infection of the colon presenting as acute attack of ulcerative colitis. Gastroenterology (1989) 1.40
[The Vancouver rules and the scientific ethical committee system]. Ugeskr Laeger (2001) 1.39
[Late postpartum eclampsia]. Ned Tijdschr Geneeskd (2007) 1.38
Attempts to detect virus-specific DNA sequences in human tumors. III. Epstein-Barr viral DNA in non-lymphoid nasopharyngeal carcinoma cells. Med Microbiol Immunol (1975) 1.35
Reference values and biological variation for tumor marker CA 19-9 in serum for different Lewis and secretor genotypes and evaluation of secretor and Lewis genotyping in a Caucasian population. Clin Chem (1999) 1.33
Phenotypic and functional characterization of CD11c+ dendritic cell population in mouse Peyer's patches. Eur J Immunol (1996) 1.33
Transforming potential of the adenovirus type 5 E4orf3 protein. J Virol (1999) 1.31
Strain-specific transcription and translation of the BamHI Z area of Epstein-Barr Virus. J Virol (1986) 1.31
Loss of adipocyte-type fatty acid binding protein and other protein biomarkers is associated with progression of human bladder transitional cell carcinomas. Cancer Res (1996) 1.29
"Hit-and-run" transformation by adenovirus oncogenes. J Virol (2001) 1.29
Epstein--Barr virus-induced cell fusion. Nature (1980) 1.29
First EBV vaccine trial in humans using recombinant vaccinia virus expressing the major membrane antigen. Dev Biol Stand (1995) 1.25
Lipoprotein(a) concentrations in women with a history of severe preeclampsia--a case control study. Thromb Haemost (1999) 1.23
Dose reduction in subsecond multislice spiral CT examination of children by online tube current modulation. Eur Radiol (2004) 1.23
Characterization of two related Epstein-Barr virus-encoded membrane proteins that are differentially expressed in Burkitt lymphoma and in vitro-transformed cell lines. Proc Natl Acad Sci U S A (1986) 1.22
Elongation factor Tu resistant to kirromycin in an Escherichia coli mutant altered in both tuf genes. Proc Natl Acad Sci U S A (1977) 1.22
Nucleoprotein complexes and DNA 5'-ends at oriP of Epstein-Barr virus. J Biol Chem (1995) 1.20
Identification of gene expression patterns in superficial and invasive human bladder cancer. Cancer Res (2001) 1.20
Thyrotropin-releasing hormone precursor: characterization in rat brain. Science (1986) 1.20
Negatively cis-acting elements in the distal part of the promoter of Epstein-Barr virus trans-activator gene BZLF1. J Gen Virol (1994) 1.19
The regulated expression of Epstein-Barr virus. III. Proteins specified by EBV during the lytic cycle. J Gen Virol (1981) 1.17
MRSA-ST398 in livestock farmers and neighbouring residents in a rural area in Germany. Epidemiol Infect (2011) 1.17
Serodiagnosis of infectious mononucleosis by using recombinant Epstein-Barr virus antigens and enzyme-linked immunosorbent assay technology. J Clin Microbiol (1990) 1.16
Sequence variability among different parvovirus B19 isolates. J Gen Virol (1996) 1.16
Priming of strong, broad, and long-lived HIV type 1 p55gag-specific CD8+ cytotoxic T cells after administration of a virus-like particle vaccine in rhesus macaques. AIDS Res Hum Retroviruses (2000) 1.15
A subclass of HER1 ligands are prognostic markers for survival in bladder cancer patients. Cancer Res (2001) 1.15
EBV DNA in nonlymphoid cells of nasopharyngeal carcinomas and in a malignant lymphoma obtained after inoculation of EBV into cottontop marmosets. Cold Spring Harb Symp Quant Biol (1975) 1.14
Specific detection of monkeypox virus by polymerase chain reaction. J Virol Methods (1998) 1.12
Perforation of continent urinary reservoirs. Scandinavian experience. Scand J Urol Nephrol (1997) 1.11
Competitive inhibition of human immunodeficiency virus type-1 protease by the Gag-Pol transframe protein. J Biol Chem (1999) 1.11
Is psychosocial stress in first ongoing pregnancies associated with pre-eclampsia and gestational hypertension? BJOG (2008) 1.10
Immunoglobulin M anti-hepatitis A virus determination reorienting gradient centrifugation for diagnosis of Acute Hepatitis A. J Clin Microbiol (1979) 1.10
Conformational response of the glycocalyx to ionic strength and interaction with modified glass surfaces: study of live red cells by interferometry. J Cell Sci (1983) 1.10
The elongation factor Tu binds aminoacyl-tRNA in the presence of GDP. J Biol Chem (1982) 1.09
Molecular alterations in bladder cancer. Urol Res (1998) 1.09
Identification of wild-type and mutant p53 peptides binding to HLA-A2 assessed by a peptide loading-deficient cell line assay and a novel major histocompatibility complex class I peptide binding assay. Eur J Immunol (1994) 1.08
Concerted action of multiple cis-acting sequences is required for Rev dependence of late human immunodeficiency virus type 1 gene expression. J Virol (2000) 1.08
Monosomy X found at first trimester CVS: a diagnostic and counselling dilemma. Clin Genet (1990) 1.07
Studies on the effect of distamycin A on the DNA dependent RNA polymerase system. Biochem Biophys Res Commun (1971) 1.07
Red blood cells experience electrostatic repulsion but make molecular adhesions with glass. Biophys J (1985) 1.07
Mapping of Epstein-Barr virus proteins on the genome by translation of hybrid-selected RNA from induced P3HR1 cells and induced Raji cells. Virology (1985) 1.06
High level expression of hepatitis B virus surface antigen in stably transfected Drosophila Schneider-2 cells. J Virol Methods (1999) 1.06
Inhibition of infectious human immunodeficiency virus type 1 particle formation by Gag protein-derived peptides. J Gen Virol (1994) 1.06
Arylamine N-acetyltransferase 1 (NAT1) and 2 (NAT2) polymorphisms in susceptibility to bladder cancer: the influence of smoking. Cancer Epidemiol Biomarkers Prev (1997) 1.05
Membrane proteins of legionellaceae. I. Membrane proteins of different strains and serogroups of Legionella pneumophila. Zentralbl Bakteriol Mikrobiol Hyg A (1985) 1.05